During the past decade, Vascular Surgery Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vascular Surgery Associates" #1 sponsor was "Proteon Therapeutics" with 2 trials, followed by "Anesiva, Inc." with 1 trials sponsored, "FoxHollow Technologies" with 1 trials sponsored, "LeMaitre Vascular" with 1 trials sponsored and "Medtronic Cardiovascular" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vascular Surgery Associates" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "University of Alabama at Birmingham" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vascular Surgery Associates" are "Chronic Kidney Disease" (2 trials), "ABDOMINAL AORTIC ANEURYSMS" (1 trials), "Atherosclerosis" (1 trials), "Carotid Stenosis" (1 trials) and "Cerebral Infarction" (1 trials). Many other conditions were trialed in "Vascular Surgery Associates" in a lesser frequency.

Most popular intervention types in "Vascular Surgery Associates" are "Drug" (4 trials), "Device" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "PRT-201" (2 trials), "Placebo" (2 trials), "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials), "Bypass" (1 trials) and "Carotid Artery Stenting (CAS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vascular Surgery Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Vascular Surgery Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Vascular Surgery Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vascular Surgery Associates, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".